Deutsche Tageszeitung - No link between paracetamol and autism, major review finds

No link between paracetamol and autism, major review finds


No link between paracetamol and autism, major review finds
No link between paracetamol and autism, major review finds / Photo: © AFP/File

There is no clear link between pregnant women taking the common painkiller paracetamol and autism in their children, despite repeated claims otherwise by Donald Trump, according to the most comprehensive review of the existing evidence published Monday.

Change text size:

In September, the US president sparked outrage among the medical community by claiming that paracetamol -- also known as acetaminophen -- was associated with higher rates of autism.

Trump urged pregnant women to "tough it out" rather than take paracetamol, comments which health researchers warned could scare women off their safest option to treat pain -- and risked further stigmatising autistic people.

The World Health Organization has emphasised that there is no robust evidence showing that paracetamol -- which is the main ingredient in massively popular painkillers such as Tylenol and Panadol -- causes autism.

On Monday, an "umbrella" review of all the scientific research yet conducted on the subject was published in the British medical journal BMJ.

"Existing evidence does not show a clear link between in utero exposure to paracetamol and autism and ADHD in offspring," the UK-lead team of researchers wrote in the review.

There have been several previous studies which suggested a possible link between paracetamol and autism or attention deficit hyperactivity disorder (ADHD).

However the quality of those studies was "low to critically low", the review said, partly because they did not take adequate steps to rule out potentially misleading factors such as whether autism runs in the family.

These controversial previous studies also could not establish exactly how paracetamol might cause autism.

The umbrella review called for better research, pointing out that there has been a "historical and ongoing underinvestment in women's health research".

- Confirmation -

Several researchers praised the new study.

Dimitrios Siassakos, professor in obstetrics and gynaecology at University College London, said the review "confirms what experts around the globe have been saying".

"Autistic and neurodivergent people are more likely to experience chronic pain, and they are also much more likely to have neurodivergent children -- but paracetamol doesn't cause neurodivergence," said Steven Kapp of the University of Portsmouth.

"As a researcher and autistic person with ADHD, I think we should not be trying to prevent neurodivergence anyway, but make life better for neurodivergent people," he added.

Beyond paracetamol, Trump and his vaccine-sceptic Health Secretary Robert F. Kennedy Jr have repeatedly made unfounded claims about autism, including that there is an "epidemic" of cases.

However experts maintain that the recent increase in autism rates is due to improved, broadened diagnosis methods along with growing awareness.

(W.Budayev--DTZ)

Featured

How to assess microplastics in our bodies? Scientists have a plan

How many tiny pieces of plastic are currently inside your body?

The Market Has Spoken: BridgeLink Surpasses 10,000 Downloads, Solidifying Status as the Global Standard for Open-Source Health Interoperability

MONTGOMERY, AL / ACCESS Newswire / January 27, 2026 / Innovar Healthcare today announced that BridgeLink, the open-source integration engine, has surpassed 10,000 enterprise downloads, a milestone that signals a decisive shift in the healthcare IT landscape. Following the market shift toward restrictive proprietary licensing for the industry's legacy engine, the healthcare community has decisively moved to BridgeLink as the premier open-source replacement.

MicroVision Announces Agreement to Acquire Luminar Assets to Accelerate Commercial Strategy and Expand Product Portfolio

REDMOND, WASHINGTON / ACCESS Newswire / January 27, 2026 / MicroVision, Inc. (NASDAQ:MVIS), a technology pioneer delivering advanced perception solutions in autonomy and mobility, today announced that it had entered into an agreement to acquire certain assets from Luminar Technologies, Inc., including IP and inventory related to the Iris and Halo lidar sensors, key engineering and operations talent, and certain commercial contracts and orders.

Symetrix Unveils Cognio: The Next-Generation Audio, Video, and Control Platform

With breakthrough distributed architecture and wire-free design workflows, Cognio redefines how AV systems are designed, deployed, and operated; see it for the first time at ISE 2026

Change text size: